Companies / Iovance Biotherapeutics, Inc. / Activity
Activity — Iovance Biotherapeutics, Inc.
41 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 5, 2026 | Graf Finckenstein Friedrich Executive | Exercise | Common Stock | $0 | +31K +26.65% | 148,477 0.03% of shares | low |
| Mar 2, 2026 | Graf Finckenstein Friedrich Executive | Exercise | Common Stock | $0 | +13K +11.37% | 124,353 0.03% of shares | low |
| Mar 5, 2026 | Vogt Frederick G CEO | Exercise | Common Stock | $0 | +62K +12.66% | 556,293 0.12% of shares | low |
| Mar 2, 2026 | Vogt Frederick G CEO | Exercise | Common Stock | $0 | +52K +11.21% | 516,609 0.11% of shares | low |
| Mar 5, 2026 | Bilinsky Igor Executive | Exercise | Common Stock | $0 | +31K +28.11% | 142,394 0.03% of shares | low |
| Mar 2, 2026 | Bilinsky Igor Executive | Exercise | Common Stock | $0 | +12K +11.64% | 118,051 0.03% of shares | low |
| Mar 5, 2026 | Puri Raj K. Executive | Exercise | Common Stock | $0 | +39K +17.87% | 257,590 0.06% of shares | low |
| Mar 2, 2026 | Puri Raj K. Executive | Exercise | Common Stock | $0 | +5K +2.53% | 221,329 0.05% of shares | low |
| Feb 24, 2026 | Kirby Daniel Gordon Executive | Exercise | Common Stock | $0 | +120K +224.11% | 173,546 0.04% of shares | low |
| Feb 10, 2026 | Kirby Daniel Gordon Executive | Exercise | Common Stock | $0 | +40K +133.32% | 69,996 0.02% of shares | low |
| Mar 2, 2026 | Puri Raj K. Executive | Other | Common Stock | $10.6K | -3K -1.26% | 218,531 0.05% of shares | low |
| Mar 2, 2026 | Bilinsky Igor Executive | Other | Common Stock | $26.2K | -7K -5.85% | 111,148 0.02% of shares | low |
| Mar 2, 2026 | Graf Finckenstein Friedrich Executive | Other | Common Stock | $27.0K | -7K -5.73% | 117,231 0.03% of shares | low |
| Feb 10, 2026 | Kirby Daniel Gordon Executive | Other | Common Stock | $42.8K | -16K -23.50% | 53,546 0.01% of shares | low |
| Mar 5, 2026 | Graf Finckenstein Friedrich Executive | Other | Common Stock | $75.7K | -17K -11.13% | 131,957 0.03% of shares | low |
| Mar 5, 2026 | Bilinsky Igor Executive | Other | Common Stock | $76.2K | -17K -11.68% | 125,766 0.03% of shares | low |
| Mar 5, 2026 | Puri Raj K. Executive | Other | Common Stock | $84.1K | -18K -7.13% | 239,230 0.05% of shares | low |
| Mar 2, 2026 | Vogt Frederick G CEO | Other | Common Stock | $86.4K | -23K -4.42% | 493,800 0.11% of shares | low |
| Mar 5, 2026 | Vogt Frederick G CEO | Other | Common Stock | $122.5K | -27K -4.81% | 529,538 0.12% of shares | low |
| Feb 24, 2026 | Kirby Daniel Gordon Executive | Other | Common Stock | $129.1K | -34K -19.69% | 139,381 0.03% of shares | low |
| Jun 16, 2026 | Maynard Ryan D Director | Grant | Deferred Restricted Stock Unit | — | +90K | 90,316 0.02% of shares | low |
| Jun 16, 2026 | Weiser Michael Director | Grant | Deferred Restricted Stock Unit | — | +90K | 90,316 0.02% of shares | low |
| Mar 9, 2026 | Graf Finckenstein Friedrich Executive | Grant | Restricted Stock Units | — | +59K | 58,750 0.01% of shares | low |
| Mar 5, 2026 | Graf Finckenstein Friedrich Executive | Exercise | Restricted Stock Units | — | -31K -33.33% | 62,504 0.01% of shares | low |
| Mar 2, 2026 | Graf Finckenstein Friedrich Executive | Exercise | Restricted Stock Units | — | -4K -100.00% | 0 0.00% of shares | low |
| Mar 2, 2026 | Graf Finckenstein Friedrich Executive | Exercise | Restricted Stock Units | — | -9K -20.00% | 35,159 <0.01% of shares | low |
| Mar 9, 2026 | Vogt Frederick G CEO | Grant | Restricted Stock Units | — | +235K | 235,000 0.05% of shares | low |
| Mar 5, 2026 | Vogt Frederick G CEO | Exercise | Restricted Stock Units | — | -62K -33.33% | 125,007 0.03% of shares | low |
| Mar 2, 2026 | Vogt Frederick G CEO | Exercise | Restricted Stock Units | — | -10K -100.00% | 0 0.00% of shares | low |
| Mar 2, 2026 | Vogt Frederick G CEO | Exercise | Restricted Stock Units | — | -42K -20.00% | 166,675 0.04% of shares | low |
| Mar 9, 2026 | Bilinsky Igor Executive | Grant | Restricted Stock Units | — | +118K | 117,500 0.03% of shares | low |
| Mar 5, 2026 | Bilinsky Igor Executive | Exercise | Restricted Stock Units | — | -31K -33.33% | 62,504 0.01% of shares | low |
| Mar 2, 2026 | Bilinsky Igor Executive | Exercise | Restricted Stock Units | — | -4K -100.00% | 0 0.00% of shares | low |
| Mar 2, 2026 | Bilinsky Igor Executive | Exercise | Restricted Stock Units | — | -9K -20.00% | 35,159 <0.01% of shares | low |
| Mar 9, 2026 | Roche Corleen M. Executive | Grant | Restricted Stock Units | — | +132K | 132,200 0.03% of shares | low |
| Mar 9, 2026 | Puri Raj K. Executive | Grant | Restricted Stock Units | — | +118K | 117,500 0.03% of shares | low |
| Mar 9, 2026 | Kirby Daniel Gordon Executive | Grant | Restricted Stock Units | — | +132K | 132,200 0.03% of shares | low |
| Mar 5, 2026 | Puri Raj K. Executive | Exercise | Restricted Stock Units | — | -39K -33.33% | 78,131 0.02% of shares | low |
| Mar 2, 2026 | Puri Raj K. Executive | Exercise | Restricted Stock Units | — | -5K -20.00% | 21,878 <0.01% of shares | low |
| Feb 24, 2026 | Kirby Daniel Gordon Executive | Exercise | Restricted Stock Units | — | -150K -100.00% | 0 0.00% of shares | low |
| Feb 10, 2026 | Kirby Daniel Gordon Executive | Exercise | Restricted Stock Units | — | -40K -33.33% | 80,004 0.02% of shares | low |